Differential Diagnoses and Treatment Plan
Immediately discontinue doxycycline and initiate a PPI (proton pump inhibitor) with sucralfate for 4-8 weeks, as doxycycline-induced esophageal and gastric injury is the most likely diagnosis given the temporal relationship and characteristic presentation 1, 2.
Primary Differential Diagnoses
1. Doxycycline-Induced Gastrointestinal Mucosal Injury (Most Likely)
- Esophageal ulceration: The most common manifestation, occurring even after a single dose if taken improperly (without adequate fluids or before bedtime) 1, 2
- Gastric injury: Less common but well-documented, characterized by distinctive capillary degeneration with fibrinoid material around small vessels 3
- Simultaneous esophageal and gastric ulceration: Rare but reported 4
Key clinical features to identify:
- Onset within hours to days of doxycycline ingestion
- Severe chest pain, odynophagia, dysphagia
- Abdominal pain if gastric involvement present
- History of taking medication without adequate fluids or before lying down
2. Gastroesophageal Reflux Disease (GERD)
May coexist or be exacerbated by doxycycline injury. Typical symptoms include heartburn and regurgitation 5.
3. Peptic Ulcer Disease
Consider if symptoms persist after doxycycline cessation.
4. Functional Esophageal Disorder
Only if objective testing excludes structural disease and pathologic acid exposure 5.
Immediate Treatment Plan
Step 1: Drug Cessation and Acute Management
- Stop doxycycline immediately 1, 2
- Initiate PPI therapy: Standard once-daily dosing for 4-8 weeks 5, 2
- Add sucralfate: Promotes mucosal healing in esophageal ulceration 2
- Instruct liberal fluid intake: Reduces risk of further esophageal irritation 1
Step 2: Diagnostic Evaluation
Upper endoscopy is indicated to:
- Confirm doxycycline-induced injury (look for longitudinal ulcers in distal esophagus, fundic/pyloric erosions or ulcers) 2, 3, 4
- Exclude alternative diagnoses
- Assess severity of mucosal damage
- Rule out Barrett's esophagus if chronic GERD suspected 5
Characteristic endoscopic findings:
- Multiple longitudinal esophageal ulcers (typically distal)
- Fundic and pyloric erosions/ulcers if gastric involvement
- Distinctive histology: small vessel injury with fibrinoid material 3
Step 3: GERD Assessment (if symptoms persist after healing)
If symptoms continue beyond expected healing period (2-8 weeks):
- Optimize PPI therapy: Increase to twice-daily dosing if inadequate response 5
- Consider prolonged wireless pH monitoring off PPI: To establish true GERD diagnosis if long-term therapy contemplated 5
- High-resolution manometry: If surgical intervention considered or to exclude achalasia 5
Step 4: Long-term Management
For confirmed doxycycline injury:
- Symptoms typically improve within days of cessation 2, 3
- Complete mucosal healing occurs within 2 months 2
- Follow-up endoscopy at 2 months to confirm healing 2
- Avoid future doxycycline use; document allergy/adverse reaction
For coexisting GERD:
- Taper PPI to lowest effective dose once symptoms controlled 5
- Provide education on weight management, dietary modifications, and lifestyle behaviors 5
- Emphasize PPI safety for appropriate long-term use 5
- If PPI continued beyond 12 months without proven GERD, reassess appropriateness with objective testing 5
Critical Pitfalls to Avoid
- Continuing doxycycline: This is the most critical error—immediate cessation is mandatory 1, 2
- Assuming GERD without endoscopy: Doxycycline injury has distinctive features requiring visualization 2, 3
- Inadequate patient education: Future doxycycline prescriptions must include explicit instructions to take with full glass of water and remain upright for 30+ minutes 1
- Premature PPI discontinuation: Allow adequate healing time (4-8 weeks minimum) 2
- Missing simultaneous gastric injury: Always evaluate stomach during endoscopy, not just esophagus 3, 4
Expected Clinical Course
With appropriate management:
- Symptom improvement within 2-7 days of doxycycline cessation 2, 3
- Complete mucosal healing by 2 months 2
- Normal follow-up endoscopy if drug avoided 2, 3
If symptoms persist beyond expected timeframe, reassess for true GERD using Lyon Consensus criteria with objective testing (endoscopy, pH monitoring, manometry) 5, 6.